Similarly, as discussed, testing for OPMD (PABPN1, R75) and myotonic dystrophy type 2 (CNBP (ZNF9), R410) are only available through PCR-based tests and need to be requested additionally to the panels of interest. This evidence concerns the gene CNBP and Proximal myotonic myopathy.